Remedium Lifecare Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Remedium Lifecare Ltd is ₹ 0.39 as of 13 Apr 15:30 . The P/E Ratio of Remedium Lifecare Ltd is 0 as of March 2023 .The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 . The Market Cap of Remedium Lifecare Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 . The revenue of Remedium Lifecare Ltd for the Sep '25 is ₹ 114.31 crore as compare to the Jun '25 revenue of ₹ 116.84 crore. This represent the decline of -2.17% The revenue of Sandu Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Remedium Lifecare Ltd for the Sep '25 is ₹ 10.62 crore as compare to the Jun '25 ebitda of ₹ 5.35 crore. This represent the growth of 98.5% The ebitda of Sandu Pharmaceuticals Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 8.62 crore over 3 quarters. This represents a CAGR of NaN% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 years .

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd (SPL) was established in 1985.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.
Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

FAQs for the comparison of Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Remedium Lifecare Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Remedium Lifecare Ltd is 40 Cr while Market cap of Sandu Pharmaceuticals Ltd is 42 Cr

What are the key factors driving the stock performance of Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd?

As of May 4, 2026, the Remedium Lifecare Ltd stock price is INR ₹0.46. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹44.0.

How do dividend payouts of Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Remedium Lifecare Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.